CollPlant Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P. as Chairman of the Board of Directors

REHOVOT, Israel, Feb. 10, 2020 -- (Healthcare Sales & Marketing Network) -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, today announced the appointment of Roger J. Pomerantz, M.D., F.A.C.P. to its Board of Directors as Chairma... Regenerative Medicine, Personnel CollPlant, 3D bioprinting, recombinant human collagen, collagen
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news